T3 Defense Inc. DFNS
7.79
(0.08)
(1.02%)
as of 25 Sep
- Market cap
- $22.3M
- P/E
- 0.0×
Follow DFNS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | — | — |
+8 more quarters Free account |
P/S ratio |
1.23 | 4.41 | — | — | |
P/FCF ratio |
0.00 | 0.00 | — | — | |
P/Operating CF |
(2.11) | (4.10) | — | — | |
P/B ratio |
0.00 | 0.47 | — | — | |
Price to Tangible BV |
0.00 | 0.00 | — | — | |
EV/Sales |
1.28 | 4.28 | — | — | |
EV/EBITDA |
0.00 | 0.00 | — | — | |
EV/Operating CF |
(0.80) | (2.01) | — | — | |
EV/FCF |
(0.78) | (1.96) | — | — | |
Quick Ratio |
0.07 | 0.13 | 0.11 | 0.17 | |
Current Ratio |
0.14 | 0.25 | 0.31 | 0.30 | |
Net Debt/EBITDA |
(0.13) | 0.16 | 0.13 | 1.60 | |
Debt/Assets |
2.47% | 2.30% | 0.43% | 0.00% | |
Debt/Equity |
(0.40) | 0.17 | (0.06) | 0.00 | |
Asset Turnover |
0.05 | 0.03 | 0.00 | 0.00 | |
Operating CF/Net income |
0.06 | 0.18 | 0.09 | 0.15 | |
Capex/Depreciation |
(0.72) | (0.82) | 0.04 | (8.90) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
8.71% | 7.50% | — | — | |
Selling, General and Administrative Expense of Revenue |
101.18% | 106.98% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.35 | 0.36 | 0.07 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 52.20% | 0.00% | 0.00% | |
Graham Net Nets |
(30.64) | (12.39) | — | — | |
Graham Number |
1,285.25 | 0.00 | — | — | |
Earnings Yield |
(8,384.27%) | (1,886.93%) | — | — | |
Free Cash Flow Yield |
(133.71%) | (49.67%) | — | — | |
Revenue per Share |
8.33 | 16.21 | 0.00 | 0.00 | |
Operating CF per Share |
(10.13) | (21.87) | (14.93) | (38.54) | |
Capex per Share |
(0.37) | (0.68) | (0.18) | (0.29) | |
Free Cash Flow per Share |
(10.51) | (22.55) | (15.11) | (38.83) | |
Cash per Share |
15.37 | 34.69 | 62.74 | 117.10 | |
Shareholders Equity per Share |
(40.96) | 188.74 | (232.87) | (467.97) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(40.96) | 188.74 | (232.87) | (467.97) | |
Free Cash Flow |
(5.04) | (5.08) | (1.01) | (2.52) | |
Working Capital |
(131.95) | (68.81) | (29.99) | (30.51) | |
Capital Expenditures |
(0.18) | (0.15) | (0.01) | (0.02) | |
Net Current Asset Value |
(314.42) | (250.15) | (204.41) | (30.59) | |
EV/EBIT |
0.00 | 0.00 | — | — | |
Capex to Sales |
0.05 | 0.04 | 0.00 | 0.00 | |
Net Profit Margin |
(2,037.79%) | (743.14%) | 0.00% | 0.00% | |
Price to Operating Income |
0.00 | 0.00 | — | — | |
| Other line items | |||||
Average Receivables |
2.29 | 2.05 | — | — | |
Average Payables |
2.43 | 5.57 | 0.10 | 0.68 | |
Average Assets |
161.57 | 162.04 | 105.75 | 6.64 | |
Average Common Equity |
(36.52) | (7.35) | (89.46) | (18.76) |
Columns are period end dates